Home Tools
Log in

Dovitinib lactate

Catalog No. T7104   CAS 692737-80-7
Synonyms: TKI-258 lactate, CHIR-258 lactate

Dovitinib lactate(TKI258) lactate is a potent inhibitor of fibroblast growth factor receptor 3 (FGFR3) (IC50 :5 nM).

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.
Dovitinib lactate Chemical Structure
Dovitinib lactate, CAS 692737-80-7
Pack Size Availability Price/USD Quantity
5 mg In stock $ 47.00
10 mg In stock $ 72.00
25 mg In stock $ 131.00
50 mg In stock $ 225.00
100 mg In stock $ 376.00
200 mg In stock $ 563.00
500 mg In stock $ 888.00
1 mL * 10 mM (in DMSO) In stock $ 52.00
Bulk Inquiry
Get quote
Select Batch  
Purity: 100%
Purity: 98.44%
Contact us for more batch information
Biological Description
Chemical Properties
Storage & Solubility Information
Description Dovitinib lactate(TKI258) lactate is a potent inhibitor of fibroblast growth factor receptor 3 (FGFR3) (IC50 :5 nM).
Targets&IC50 FGFR3:5 nM
In vitro ALL cells were extremely sensitive to TKI258 treatment with a concentration for 50% inhibition of cell proliferation (IC50) values in the nanomolar range in vitro.?By combination with mTOR inhibitor RAD001, a synergistic effect on cell death and cell proliferation was observed in these cells[1].Treatment of SK-HEP1 cells with dovitinib resulted in G2/M cell cycle arrest, inhibition of colony formation in soft agar and blockade of bFGF-induced cell migration. Dovitinib inhibited basal expression and FGF-induced phosphorylation of FGFR-1, FRS2-α and ERK1/2[2]
In vivo In vivo, dovitinib potently inhibited tumor growth of six HCC lines.?Inhibition of angiogenesis correlated with inactivation of FGFR/PDGFR-β/VEGFR-2 signaling pathways.?Dovitinib also caused dephosphorylation of retinoblastoma, upregulation of p-histone H2A-X and p27, and downregulation of p-cdk-2 and cyclin B1, which resulted in a reduction in cellular proliferation and the induction of tumor cell apoptosis.?In an orthotopic model, dovitinib potently inhibited primary tumor growth and lung metastasis and significantly prolonged mouse survival[2].
Cell Research Determination of cell proliferation by 3,[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT) assay.?Different leukemic cells were seeded into a 96-well plate at a density of 5×10^3 cells per well and exposed to different concentrations of TKI258, with or without RAD001, in culture medium.?After incubation for indicated time points.Cell-cycle analysis:For cell-cycle analysis, cells were exposed to different concentrations of TKI258, with or without RAD001, in growth medium.?After different culture durations, cells were harvested and fixed in 70% ethanol at 4°C for over 30 min. After incubation for indicated time points, DNA contents were stained.Apoptosis analysis:Cell apoptosis was detected by determining phosphatidylserine expression on the cell surface[1].
Animal Research 21-0208 and SK-HEP1 cells as well as patient-derived HCC models were employed to study the antitumor effect of dovitinib.?Changes of biomarkers relevant to FGFR/VEGFR/PDGFR pathways were determined by Western blotting.?Microvessel density, apoptosis and cell proliferation were analyzed by immunohistochemistry[1].
Synonyms TKI-258 lactate, CHIR-258 lactate
Molecular Weight 482.51
Formula C24H27FN6O4
CAS No. 692737-80-7


Powder: -20°C for 3 years | In solvent: -80°C for 2 years

Solubility Information

DMSO: 30 mg/mL (62.17 mM)

( < 1 mg/ml refers to the product slightly soluble or insoluble )

References and Literature

1. Eucker J , Zang C , Zhou Y , et al. TKI258, a Multi-tyrosine Kinase Inhibitor Is Efficacious Against Human Infant/Childhood Lymphoblastic Leukemia In Vitro[J]. Anticancer research, 2014, 34(9):4899-4907. 2. Huynh H , Chow P K H , Tai W M , et al. Dovitinib demonstrates antitumor and antimetastatic activities in xenograft models of hepatocellular carcinoma[J]. Journal of Hepatology, 2012, 56(3):0-601.

Related compound libraries

This product is contained In the following compound libraries:
Anti-Cancer Clinical Compound Library Inhibitor Library Anti-Pancreatic Cancer Compound Library Anti-Lung Cancer Compound Library Anti-Liver Cancer Compound Library Anti-Cancer Active Compound Library Anti-Prostate Cancer Compound Library Anti-Cancer Compound Library Bioactive Compound Library Anti-Cancer Drug Library

Related Products

Related compounds with same targets
CT52923 KN1022 PDGFR Tyrosine Kinase Inhibitor III Imatinib impurities3 AXL-IN-13 CP-547632 Eupatolide PDGFRα kinase inhibitor 1

Dose Conversion

You can also refer to dose conversion for different animals. More

In vivo Formulation Calculator (Clear solution)

Step One: Enter information below
Average weight of animals
Dosing volume per animal
Number of animals
Step Two: Enter the in vivo formulation
% Tween 80
% ddH2O
Calculate Reset


Molarity Calculator
Dilution Calculator
Reconstitution Calculation
Molecular Weight Calculator

Molarity Calculator allows you to calculate the

  • Mass of a compound required to prepare a solution of known volume and concentration
  • Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Concentration of a solution resulting from a known mass of compound in a specific volume
See Example

An example of a molarity calculation using the molarity calculator
What is the mass of compound required to make a 10 mM stock solution in 10 ml of water given that the molecular weight of the compound is 197.13 g/mol?
Enter 197.13 into the Molecular Weight (MW) box
Enter 10 into the Concentration box and select the correct unit (millimolar)
Enter 10 into the Volume box and select the correct unit (milliliter)
Press calculate
The answer of 19.713 mg appears in the Mass box


Calculator the dilution required to prepare a stock solution

Calculate the dilution required to prepare a stock solution
The dilution calculator is a useful tool which allows you to calculate how to dilute a stock solution of known concentration. Enter C1, C2 & V2 to calculate V1.

See Example

An example of a dilution calculation using the Tocris dilution calculator
What volume of a given 10 mM stock solution is required to make 20ml of a 50 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=50 μM, V2=20 ml and V1 is the unknown:
Enter 10 into the Concentration (start) box and select the correct unit (millimolar)
Enter 50 into the Concentration (final) box and select the correct unit (micromolar)
Enter 20 into the Volume (final) box and select the correct unit (milliliter)
Press calculate
The answer of 100 microliter (0.1 ml) appears in the Volume (start) box


Calculate the volume of solvent required to reconstitute your vial.

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial.
Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Enter the chemical formula of a compound to calculate its molar mass and elemental composition

Tip: Chemical formula is case sensitive: C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed n the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.


Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.


Dovitinib lactate 692737-80-7 Angiogenesis Tyrosine Kinase/Adaptors PDGFR c-Kit VEGFR FGFR FLT TKI-258 lactate CHIR-258 Dovitinib SCFR CD117 Platelet-derived growth factor receptor TKI258 TKI 258 CHIR258 CHIR-258 lactate CD135 FLT3 CHIR 258 Fms like tyrosine kinase 3 Inhibitor Cluster of differentiation antigen 135 Vascular endothelial growth factor receptor inhibit TKI-258 Fibroblast growth factor receptor inhibitor